Revenue from operations stood at Rs 603.05 crore, up 7.14% YoY from Rs 562.86 crore and 1.88% higher than Rs 591.91 crore in the March quarter.
Profit before tax and exceptional items stood at Rs 259.53 crore in Q1 FY26, up 28.09% YoY and up 2.59% from Rs 252.99 crore in Q4 FY25.
Total expenditure rose 1.99% YoY to Rs 393.03 crore from Rs 385.37 crore and was up 7.86% sequentially from Rs 364.41 crore. Cost of material consumed jumped 53.60% YoY to Rs 88.69 crore in Q1 FY26.
Pfizer is one of the world’s leading pharmaceutical companies, specialising in four key business categories — vaccines, hospitals, internal medicine, and inflammation & immunology.
"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."